SSRI antidepressants and birth defects

Prescrire International

Volumn 15, Issue 86, 2006, Pages 222-223

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SODIUM;

ARTICLE; BIRTH DEFECT; CASE CONTROL STUDY; CLINICAL PRACTICE; COHORT ANALYSIS; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CRANIOFACIAL SYNOSTOSIS; DENMARK; DEPRESSION; DISEASE ASSOCIATION; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPONATREMIA; ISRAEL; ITALY; MEDICAL DECISION MAKING; MEDICAL INFORMATION SYSTEM; MUSCLE DISEASE; OMPHALOCELE; PERINATAL DRUG EXPOSURE; PREGNANCY; PRESCRIPTION; PROGENY; REGISTER; RESTLESSNESS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEIZURE; SWEDEN; TERATOGENICITY; UNITED STATES;

ABNORMALITIES, DRUG-INDUCED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CLINICAL TRIALS; COHORT STUDIES; COST-BENEFIT ANALYSIS; DENMARK; DEPRESSION; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; PAROXETINE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN UPTAKE INHIBITORS; SWEDEN; TERATOGENS; UNITED STATES;

EID: 34547650422     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Prescnre Editorial Staff "SSRI antidepressants: neonatal complications after intrauterine exposure Prescrire Int 2004; 13 (71): 103-104.
2. Prescrire Rédaction "Nouveau-nés exposés aux IRS en fin de grossesse: troubles neurologiques et hyponatrémie" Rev Prescrire 2005; 25 (265): 675.
3. Sanz EJ et al. "Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis" Lancet 2005; 365: 482-487.
4. Prescrire Editorial Staff "Serotonin reuptake inhibitor antidepressants and pregnancy" Prescrire Int 1999; 8 (43): 157-159.
5. Wogelius P et al. "Maternal use of selective serotonin reuptake inhibitors and risk of adverse pregnancy outcomes (abstract)" Pharmacoepidemiol Drug Saf 2005; 14 (suppl.): 72.
6. GlaxoSmithKline "Study N°: EPIP083 (preliminary report)" 6 September 2005. Website http://ctr.gsk.co.uk accessed 11 October 2005.
7. GlaxoSmithKline "Important prescribing information" September 2005 + December 2005. Website http://www.fda.gov accessed 22 December 2005.
8. Källén B "Paroxetine in early pregnancy and cardiac malformation in the child" 6 December 2005. Website http://www.mhra.gov.uk accessed 19 December 2005.
9. Alwan S et al. "Maternal use of selective serotonin re-uptake inhibitors and risk for birth defects (abstract)" Teratology Society Abstracts 2005: 291.
10. Diav-Citrin O et al. "Paroxetine and fluoxetine in pregnancy: a multicenter, prospective, controlled study" Reprod Toxicol 2005; 20: 453-491.
11. Agence française de sécurité sanitaire des produits de santé "Lettre GlaxoSmithKline" 3 March 2006. Website http://afssaps.sante.fr accessed 4 April 2006.
12. Vial T et al. "Paroxetine and congenital malformations: a prospective comparative study" Fundamental Clin Pharmacol 2006; 20: 182 (abstr. 228).